Efficacy and Safety of Natalizumab and Vedolizumab in the Treatment of Crohn’s Disease: A Systematic Review and Meta-Analysis

Background — This study compared the effectiveness and safety of natalizumab and vedolizumab in managing Crohn’s disease (CD), focusing on clinical remission, response to therapy, and adverse events. Material and Methods — A systematic review conducted using the PRISMA guidelines included 11 studies...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ni Putu Sri Indrani Remitha, Ni Putu Rista Pradnya Dewi, I Komang Wira Ananta Kusuma, I Gede Aswin Parisya Sasmana, I Gede Putu Supadmanaba, Dwijo Anargha Sindhughosa, I Ketut Mariadi
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Limited liability company «Science and Innovations» (Saratov) 2025-09-01
Colección:	Russian Open Medical Journal
Materias:	crohn’s disease natalizumab vedolizumab
Acceso en línea:	https://romj.org/node/626
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!